VIRTUAL
Vaccine Virtual Days 2022
March 30-31, 2022
Congress Presentations
View congress resources from GSK Vaccines
Material supplied by the above-country business unit to LOCs for localisation must be subject to local Medical and/or Regulatory review and approval prior to use and/or external distribution.
LOCs to insert local adverse events reporting procedure.
© 2023 GSK group of companies or its licensor. GlaxoSmithKline Biologicals SA. Rixensart, Belgium.
NX-GBL-GVX-WCNT-220010 | July 2023